Biotechnology Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3852 |  ADCT ADC Therapeutics SA Common Shares | 0.98 USD | -1.01% | -7.55% | -16.24% | -69.18% | 125.11 M USD | ||
| 3857 |  NTHI NeOnc Technologies Holdings, Inc. - Common Stock | 4.68 USD | 0.00% | +12.77% | +36.44% | -46.64% | 121.38 M USD | ||
| 3859 |  VANI Vivani Medical, Inc. - Common Stock | 1.37 USD | -0.72% | +0.74% | +5.38% | +10.48% | 123.58 M USD | ||
| 3864 |  RANI Rani Therapeutics Holdings, Inc. - Class A Common Stock | 0.87 USD | -1.14% | +10.13% | +6.10% | +40.32% | 121.27 M USD | ||
| 3869 |  ANIX Anixa Biosciences, Inc. - Common Stock | 3.70 USD | -0.27% | +9.79% | -0.27% | +22.52% | 125.89 M USD | ||
| 3872 |  BMEA Biomea Fusion, Inc. - Common Stock | 1.65 USD | +20.44% | +20.44% | +30.95% | -10.81% | 119.60 M USD | ||
| 3873 |  GUTS Fractyl Health, Inc. - Common Stock | 0.75 USD | -3.85% | +8.70% | -5.06% | -25.00% | 119.38 M USD | ||
| 3875 |  GNLX Genelux Corporation - Common Stock | 2.63 USD | -3.31% | -1.50% | -11.15% | -30.24% | 119.00 M USD | ||
| 3879 |  ENGN enGene Therapeutics Inc. - Common Stock | 1.80 USD | +1.12% | +4.65% | -2.70% | -78.57% | 120.58 M USD | ||
| 3889 |  COYA Coya Therapeutics, Inc. - Common Stock | 4.92 USD | +1.03% | +4.24% | +13.63% | -31.19% | 115.41 M USD | ||
| 3892 |  SEER Seer, Inc. - Class A Common Stock | 2.06 USD | +1.48% | +0.98% | +4.04% | -0.96% | 114.07 M USD | ||
| 3896 |  NAUT Nautilus Biotechnology, Inc. - Common Stock | 0.89 USD | -6.32% | -2.20% | -47.95% | +27.14% | 113.26 M USD | ||
| 3920 |  ONCY Oncolytics Biotech Inc. - Common Stock | 0.83 USD | -1.19% | -2.35% | +3.75% | -17.82% | 105.83 M USD | ||
| 3956 |  FBIO Fortress Biotech, Inc. - Common Stock | 2.91 USD | +1.39% | +2.46% | -13.39% | +27.63% | 97.05 M USD | ||
| 3959 |  KLRS Kalaris Therapeutics, Inc. - Common Stock | 4.12 USD | -0.72% | +1.73% | +9.87% | -59.73% | 98.08 M USD | ||
| 3961 |  ATRA Atara Biotherapeutics, Inc. - Common Stock | 9.43 USD | -2.78% | +14.16% | +17.00% | -36.07% | 94.66 M USD | ||
| 3971 |  ACRV Acrivon Therapeutics, Inc. - Common Stock | 2.20 USD | -0.45% | +11.68% | +35.80% | +64.18% | 94.28 M USD | ||
| 3975 |  PYPD PolyPid Ltd. - Ordinary Shares | 5.15 USD | +0.98% | +6.19% | +30.38% | +49.28% | 93.75 M USD | ||
| 3978 |  CGTX Cognition Therapeutics, Inc. - Common Stock | 0.98 USD | -2.00% | -4.85% | +4.26% | -68.99% | 93.19 M USD | ||
| 3980 |  ALDX Aldeyra Therapeutics, Inc. - Common Stock | 1.54 USD | +1.32% | -1.28% | +0.65% | -73.54% | 92.90 M USD |
Nachrichten Biotechnology Stocks
Alto Neuroscience Aktie erreicht Allzeithoch bei 35,42 USD
Deutsche Bank stuft Argenx Aktie wegen Bewertung auf ’Hold’ herab
Klinischer Meilenstein ohne Kursschub: Aktie von Monte Rosa Therapeutics unter Druck
Biomea Fusion Aktie mit Kurssprung nach Abschluss der Rekrutierung für Diabetes-Studie
Monte Rosa Aktie fällt nach Start von Phase-2-Studie zu Prostatakrebs
ROUNDUP/Aktien New York: Chipwerte belasten Nasdaq kräftig - Dow leicht im Plus
Crinetics Pharmaceuticals Aktie erreicht Allzeithoch bei 84,8 USD
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.08 | +642.86% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0026 | +160.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.65 | +20.44% |
 APRE Aprea Therapeutics, Inc. - Common Stock | 0.75 | +17.19% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.81 | +16.77% |
 BCTXZ BriaCell Therapeutics Corp. - Warrant | 0.1201 | +14.38% |
 CRDF Cardiff Oncology, Inc. - Common Stock | 1.00 | +13.64% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0045 | -50.00% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 7.84 | -26.87% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.09 | -18.17% |
 ADXN Addex Therapeutics Ltd - American Depositary Shares | 4.14 | -16.19% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.0928 | -15.48% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTXL BriaCell Therapeutics Corp. - Warrants | 0.9500 | -12.04% |